Background
==========

The incidence of kidney stone in patients with autosomal dominant polycystic kidney disease (ADPKD) is approximately 5 to 10 folds of that in the general population \[[@B1]-[@B3]\]. The high incidence of nephrolithiasis is thought to be the consequence of the combination of anatomic abnormality and metabolic risk factors in ADPKD patients \[[@B4]\]. However, complete staghorn calculus in ADPKD is rare and the causes of staghorn calculus in ADPKD remains elusive. As existence of staghorn calculus predicts poor prognosis of kidneys \[[@B5],[@B6]\], the causes for staghorn calculus in ADPKD are of interests of nephrologists.

Here we report a case of complete staghorm calculus in an ADPKD patient induced by repeatedly upper urinary tract infections.

Case presentation
=================

A 37-year-old ADPKD female patient with positive family history was admitted in this hospital for repeatedly urinary tract infection for 3 years. Three years ago, the patient was admitted in community hospital for urinary tract irritation with right flank pain and fever for 2 days, and right upper urinary tract infection was considered. After admission, bilateral enlarged kidneys full of fluid-filled cysts were detected by type-B ultrasound examination, and there were no calculus or crystals in the kidneys detected at that time. ADPKD was diagnosed considering her family history. Since then, she suffered from urinary tract infection every 3--4 months, and urine cultures were negative. Symptoms usually were relieved within a week with antibiotics therapy, but the infections relapsed easily.

One week before admission, this patient's urinary irritation relapsed with high fever. As oral antibiotics were not responsive, she was admitted in this hospital for further treatment. On admission, her temperature was 39.0°C, blood pressure 110/82 mmHg. Physical examination revealed the bilateral enlarged kidneys that were palpable, tenderness existed in right flank area. Full blood cell count showed white blood cell count 11.1 × 10^9^/l, hemoglobin 12.3 g/dl and platelets 157 × 10^9^/l. A serum biochemical profile showed her renal function was normal with serum creatinine 0.74 mg/dl. Liver function and electrolytes were unremarkable. Urinalysis revealed +3 leukocytes, +2 blood, and +1 albumin. Chest radiology and electrocardiography were reported to be normal. Abdominal CT scan showed enlarged cystic kidneys and a complete staghorn calculus in the right kidney with no obvious signs of urinary tract obstruction (Figure [1](#F1){ref-type="fig"}). Wide spectrum antibiotics was administered intravenously and the symptoms relieved in 3 days.

![**CT images of a complete staghorn calculus in the right kidney in an ADPKD female.** Above the staghorn calculus and polycystic kidney in the coronal plane; Below the three-dimension reconstructed CT image of calculus and kidney.](1471-2369-14-168-1){#F1}

Percutaneous nephrolithotomy (PNL) was suggested,but the patient refused surgery as she felt well after the symptom relieved and worried about the surgical risks. To reduce the urinary tract infection and calculus formation, big volume of water intake was suggested to keep urinary output more than 2 L a day.

One month after discharge, the patient reported a "tiny stone" passed with urine, and the urinary stone component analysis showed the composition of calculus was magnesium ammonium phosphate. Considering the calculus component and the rapid formation of the staghorn calculus accompanied by the repeated upper urinary tract infections, the main cause of the staghorn calculus was determined as the repeated upper urinary tract infection in ADPKD.

Conclusions
===========

The incidence of kidney calculus in ADPKD patients ranges from 8% to 36% \[[@B1]-[@B3]\], much higher than in general population, while ADPKD with staghorn calculus is rare. In our center data, there is only one case with complete staghorn kidney calculus among 412 regularly followed ADPKD patients (221 male and 191 female) in the past twelve years.

Calcium oxalate and/or uric acid are the most components of kidney stone in ADPKD, although the percentage of metabolic disturbances was not higher in ADPKD patients with kidney calculus than without \[[@B2]\]. Patients with a larger kidney volume predominant cyst size are at a higher risk of stone formation \[[@B2],[@B4]\]. Numerous expanding kidney cysts distort the intrarenal calyceal system, which leads to urinary stasis and delayed washout of urinary crystals. Hypocitruria, aciduria and low urinary magnesium are common metabolic defects in ADPKD, and these factors facillate the formation and aggregation urinary crystal.

There are no generally accepted causes for the formation of staghorn calculi in ADPKD. In general population, staghorn calculi were traditionally believed to be synonymous with infection stone, and secondary to of UTI \[[@B7]\]. However, recent data challenged this traditional opinion. In a retrospective analysis with 52 kidneys with complete staghorn calculi, 56% of the kidney stones were metabolic and 44% were infection stones \[[@B8]\]. The rising percentage of metabolic stones were also observed in other urinary stone cases \[[@B9],[@B10]\].

In this case of ADPKD patient, the medical history and kidney stone component analysis supported that this case was a typical UTI induced complete staghorn calculus. This case showed in ADPKD patients, UTI was an important cause of staghorn calculus. As UTI is very common in ADPKD with 30%-50% patients experiencing an episode in their lifetime \[[@B11],[@B12]\], and staghorn calculi was associated with kidney fibrosis \[[@B5]\] and high long term renal deterioration rate \[[@B6]\], prompt control of UTI in ADPKD patient will be beneficial in preventing staghorn calculus formation.

For the treatment of staghorn calculi, PNL was recommended as the first therapy for most patients by AUA guideline in 2005 \[[@B7]\], while shock wave lithotripsy (SWL) monotherapy and open surgery are only indicated on few conditions \[[@B13]\]. In ADPKD patients, the principles of management of kidney stones are the same as in patients with normal kidneys, however PNL can be challenging because of the distortion of kidney anatomy by cysts compression and the cysts can come in the way of puncture and need to be aspirated before procedure \[[@B1],[@B14]-[@B16]\]. As reports on surgical treatment for nephrolithisasis in ADPKD patients are limited, it is reasonable to choose suitable therapeutic modality based on experience and expertise of each center. After removal of kidney stones, risk factors evaluation and control should always be considered to reduce the frequency of recurrent stone disease in such patients.
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